| Symbol | MNKD |
|---|---|
| Name | MANNKIND CORP |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Pharmaceutical Preparations |
| Address | 1 CASPER STREET, DANBURY, CT 06810 |
| Telephone | 818-661-5000 |
| Fax | — |
| — | |
| Website | https://www.mannkindcorp.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000899460 |
| Description | MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler. Additional info from NASDAQ: |
New Form SCHEDULE 13G - MANNKIND CORP <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001104659-26-097084 <b>Size:</b> 14 KB
Read moreBinder Steven B. 🔴 sold 39.1K shares of MANNKIND CORP (MNKD) at $4.06 Transaction Date: Aug 07, 2026 | Filing ID: 343016
Read more📋 STEVEN BINDER (Director) plans to sell 39K shares of MannKind Corporation (at $3.89 each, total $152K) Filed: Aug 07, 2026 | ID: 007817
Read moreMannKind Reports Second Quarter 2026 Financial Results and Provides Business Update
Read moreNew Form SCHEDULE 13G - MANNKIND CORP <b>Filed:</b> 2026-07-31 <b>AccNo:</b> 0002100119-26-001503 <b>Size:</b> 7 KB
Read moreMannKind Reports Positive Phase 1b INFLO-1 Results, Demonstrating Safety and Tolerability of Nintedanib DPI and Clinical Validation of Its DPI Technology in IPF
Read moreMannKind Announces FDA Approval of Furoscix ReadyFlow™, the First and Only Autoinjector Delivering IV-Equivalent Diuretic Therapy for the Treatment of Edema in Adults with Heart Failure or Chronic Kidney Disease
Read morePrentiss Christopher B 🔴 sold 22.2K shares of MANNKIND CORP (MNKD) at $4.09 Transaction Date: Jul 15, 2026 | Filing ID: 308139
Read moreMarasco Dominic 🔴 sold 3.6K shares of MANNKIND CORP (MNKD) at $4.09 Transaction Date: Jul 15, 2026 | Filing ID: 308137
Read more